Home › Schizophrenia › California › Orange
Schizophrenia clinical trials in Orange, CA
7 studies for Schizophrenia are looking for participants at sites in and around Orange (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Effect of KarXT on Urological Safety
RecruitingPhase 4
- ATP Clinical Research, Orange
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
RecruitingPhase 3
- Local Institution - 0158, Orange
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
RecruitingPhase 3
- NRC Research Institute, Orange
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
RecruitingPhase 2
- Clinical Site, Orange
Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
RecruitingObservational study
- ATP Clinical Research - Costa Mesa, Orange
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RecruitingPhase 4
- Neurocrine Clinical Site, Orange
Study of ALTO-101 in Patients With Schizophrenia
RecruitingPhase 2
- Site 5106, Orange
About Schizophrenia
Schizophrenia is a serious brain illness that can include hearing voices that aren't there and thinking others are trying to hurt them.
More about Schizophrenia on MedlinePlus
Schizophrenia trials in other cities
- Atlanta, GA21 studies
- Chicago, IL20 studies
- Little Rock, AR18 studies
- San Diego, CA15 studies
- Houston, TX14 studies
- Boston, MA14 studies
- Hollywood, FL14 studies
- Hialeah, FL13 studies
- Austin, TX12 studies
- Garden Grove, CA12 studies
- New York City, NY12 studies
- Miami, FL10 studies
Other studies in Orange
- Non-Small Cell Lung Cancer28 studies
- Metastatic Cancer21 studies
- Ovarian Cancer16 studies
- Colorectal Cancer16 studies
- Cancer (all types)15 studies
- Pancreatic Cancer15 studies
- Lung Cancer15 studies
- Liver Cancer (Hepatocellular Carcinoma)14 studies
- Melanoma14 studies
- Major Depressive Disorder13 studies
- Stomach Cancer13 studies
- Prostate Cancer13 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.